Peripherally Administered Y2-Receptor Antagonist BIIE0246 Prevents Diet-Induced Obesity in Mice With Excess Neuropeptide Y, but Enhances Obesity in Control Mice-Reference-Cited by-同舟云学术

Peripherally Administered Y2-Receptor Antagonist BIIE0246 Prevents Diet-Induced Obesity in Mice With Excess Neuropeptide Y, but Enhances Obesity in Control Mice

Published:2018-04-05 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Ailanen Liisa,Vähätalo Laura H.,Salomäki-Myftari Henriikka,Mäkelä Satu,Orpana Wendy,Ruohonen Suvi T.,Savontaus Eriika

Funder

Academy of Finland

Tekes

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference43 articles.

1. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.;Abbott;Brain Res.,2005

2. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons.;Ailanen;J. Endocrinol.,2017

3. Gut hormone PYY(3-36) physiologically inhibits food intake.;Batterham;Nature,2002

4. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism.;Billington;Am. J. Physiol.,1991

5. Sympathetic innervation of white adipose tissue and its regulation of fat cell number.;Bowers;Am. J. Physiol. Regul. Integr. Comp. Physiol.,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoreactomic study of fonturacetam effects: molecular mechanisms of influence on adipose tissue metabolism;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2024-08-03

2. Phenylpiracetam: molecular mechanisms of effects in obesity;Meditsinskiy sovet = Medical Council;2024-05-19

3. Methods of machine learning and big data analysis to establish the molecular mechanisms of the effects of racetams on the metabolism of adipose tissue;Experimental and Clinical Gastroenterology;2024-05-18

4. Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY3-36, and Empagliflozin on Early MASLD in Diet-Induced Obese Rats;Nutrients;2024-03-21

5. The molecular signaling of exercise and obesity in the microbiota-gut-brain axis;Frontiers in Endocrinology;2022-07-28